DE&I

April 26th 2024

A look at the lessons learned from one platform approach to study enrollment tracking—and the wider quest for accountability in achieving diversity and inclusion goals.

April 23rd 2024

A representative sample patient population that accurately reflects the overall population is vital to establish the safety and efficacy of a drug.

April 8th 2024

Systematic review of research articles sought to identify and characterize different technologies being used in clinical studies.

April 3rd 2024

In part 2 of this video interview with ACT editor Andy Studna, Tirisham Gyang, MD, assistant professor of neurology at The Ohio State University discusses how industry can effectively enroll patients from underrepresented populations into their trials.